The Safety of Intravenous Iron Dextran (Dexferrum®) During Hemodialysis in Patients with End Stage Renal Disease

The Safety of Intravenous Iron Dextran (Dexferrum®) During Hemodialysis in Patients with End Stage Renal Disease


Identification: nnj_jf00A2
Issue: January-February 2000
Volume: Vol. 27, No. 1

Standard: $ 30.00

Description

This article is available to members for free.

Note: Supported in part by American Regent Laboratories, Inc.

Author(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.

References